H. Yanai

K. Fujise, T. Koyama, M. Mukaide, 2010, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol.

H. Chiba, G. Jamieson, H. Yanai, 2000, American journal of medical genetics.

Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives

H. Yanai, H. Yoshida, 2019, International journal of molecular sciences.

Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal expression, kinetic analysis of isoforms, and comparison with prototypical SULT2A1.

H. Yanai, C. Shimizu, C. Strott, 2003, Endocrinology.

Severe hypoglycemia in a patient with anorexia nervosa

N. Tada, H. Yanai, H. Yoshida, 2008, Eating and weight disorders : EWD.

Abdominal Abscess due to Perforation of the Terminal Ieum Caused by a Fish Bone Treated by the Conservative Treatment Using Antibiotics

H. Hamasaki, H. Yanai, M. Hakoshima, 2017 .

A simple hepatic cyst with elevated serum and cyst fluid CA19-9 levels: a case report

N. Tada, H. Yanai, 2008, Journal of medical case reports.

Diabetic Ketosis Caused by the Insulin Analog Aspart–Induced Anti-Insulin Antibody: Successful Treatment With the Newest Insulin Analog Glulisine

H. Hamasaki, H. Yanai, Hiroki Adachi, 2011, Diabetes Care.

Thyroid Hormone and Dementia

H. Yanai, 2019 .

Pulmonary congestion due to hypothyroidism and nephrotic syndrome induced by cold agglutinins

Yuriko Tanaka, H. Hamasaki, H. Yanai, 2014, Annals of Hematology.

Usefulness of Scintigraphy to Evaluate Adrenal Tumors

H. Yanai, Hiroki Hashimoto, Tadanao Harigae, 2018 .

Changes in Antidiabetic Drug Prescription and Glycemic Control Trends in Elderly Patients with Type 2 Diabetes Mellitus from 2005-2013: An Analysis of the National Center Diabetes Database (NCDD-03)

K. Ohe, Y. Iwamoto, R. Yamamoto-Honda, 2017, Internal medicine.

Real-World Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist, Dulaglutide, on Metabolic Parameters in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study

H. Katsuyama, H. Yanai, Hiroki Adachi, 2023, Biomedicines.

Comparison of severe hyponatremia in patients with and without psychiatric diseases: A single‐center retrospective study

H. Hamasaki, Akahito Sako, H. Yanai, 2023, Psychiatry and Clinical Neurosciences Reports.

A patient with Graves’ disease showing only psychiatric symptoms and negativity for both TSH receptor autoantibody and thyroid stimulating antibody

H. Hamasaki, H. Yanai, Taro Yoshimi, 2012, Thyroid Research.

A significant association of plasma serotonin to cardiovascular risk factors and changes in pulse wave velocity in patients with type 2 diabetes.

H. Yanai, Y. Hirowatari, 2012, International journal of cardiology.

Colonic diverticular haemorrhage is associated with atherosclerosis.

T. Koyama, H. Yanai, K. Otani, 2005, QJM : monthly journal of the Association of Physicians.

Emphysematous Pyelonephritis in a Patient With Hyperosmolar Hyperglycemic Syndrome

H. Yanai, K. Sekine, 2011 .

Myositis, Vasculitis, Hepatic Dysfunction in Adult-Onset Still's Disease

N. Tada, H. Yanai, H. Yoshida, 2009, Case reports in medicine.

Unique character and metabolism of high density lipoprotein (HDL) in fetus.

Kunihiko Kobayashi, H. Chiba, H. Yanai, 2002, Atherosclerosis.

Effects of simvastatin 20 mg/d on serum lipid profiles in Japanese hyperlipidemic patients: A prospective, open-label pilot study.

N. Tada, H. Yanai, H. Yoshida, 2005, Current therapeutic research, clinical and experimental.

Glucagon-Like Peptide 1 Receptor Agonists Versus Sodium-Glucose Cotransporter 2 Inhibitors for Atherosclerotic Cardiovascular Disease in Patients With Type 2 Diabetes

H. Katsuyama, H. Yanai, Hiroki Adachi, 2023, Cardiology research.

The underlying mechanisms for development of hypertension in the metabolic syndrome

Hidekatsu Yanai, Norio Tada, N. Tada, 2008, Nutrition Journal.

Significant association between fluctuations in serum urate and high density lipoprotein cholesterol during exhaustive training

H. Yanai, M. Morimoto, 2003, British journal of sports medicine.

Correlations of non-exercise activity thermogenesis to metabolic parameters in Japanese patients with type 2 diabetes

O. Ezaki, R. Yamamoto-Honda, M. Kakei, 2013, Diabetology & Metabolic Syndrome.

Development of diabetes in a familial amyotrophic lateral sclerosis patient carrying the I 113 T SOD 1 mutation

K. Abe, H. Yoshino, H. Hamasaki, 2015 .

A significant association between physical restraint and the development of venous thromboembolism in psychiatric patients.

Kazunori Makino, Akahito Sako, H. Yanai, 2012, International journal of cardiology.

The association between daily physical activity and plasma B-type natriuretic peptide in patients with glucose intolerance: a cross-sectional study

O. Ezaki, M. Kakei, H. Hamasaki, 2015, BMJ Open.

Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment

H. Katsuyama, H. Yanai, Hiroki Adachi, 2022, International journal of molecular sciences.

Associations between lower extremity muscle mass and metabolic parameters related to obesity in Japanese obese patients with type 2 diabetes

H. Katsuyama, H. Hamasaki, S. Moriyama, 2015, PeerJ.

A Significant Effect of Oral Semaglutide on Cardiovascular Risk Factors in Patients With Type 2 Diabetes

H. Katsuyama, H. Yanai, Hiroki Adachi, 2022, Cardiology research.

Hospitalization for urinary tract infections in Japan, 2010–2015: a retrospective study using a national inpatient database

H. Yasunaga, K. Fushimi, Yoshiaki Gu, 2021, BMC Infectious Diseases.

A Difficult Differential Diagnosis of Acute Cholecystitis in a Patient With Steroid-induced Diabetes

Akahito Sako, H. Yanai, M. Nishida, 2011, Journal of clinical medicine research.

A Significance of High Prevalence of Diabetes and Hypertension in Severe COVID-19 Patients

H. Yanai, 2020, Journal of clinical medicine research.

Which Is the Best Treatment for Diabetes Complicated With Severe Obesity, Intensive Insulin Therapy or Basal Supported Oral Therapy or Glucagon-Like Peptide-1 Analog?

S. Moriyama, H. Yanai, 2011 .

Clinical, Hematological, Biochemical and Radiological Characteristics for Patients With Splenic Infarction: Case Series With Literature Review

H. Katsuyama, H. Yanai, Hiroki Adachi, 2023, Journal of Clinical Medicine Research.

A positive family history of hypertension might be associated with an accelerated onset of type 2 diabetes: Results from the National Center Diabetes Database (NCDD-02).

Kazuhiko Ohe, Yoshihiko Takahashi, Shigeo Yamashita, 2017, Endocrine journal.

Clinical, Biochemical, Hematological, Endocrinological and Immunological Differences Between Graves’ Disease Patients With and Without Thyroid Storm

H. Katsuyama, H. Yanai, M. Hakoshima, 2019, Journal of Clinical Medicine Research.

Atherosclerosis imaging in statin intervention trials.

N. Tada, H Yanai, H Yoshida, 2007, QJM : monthly journal of the Association of Physicians.

Differential Diagnosis of Thyrotoxicosis

H. Yanai, 2019, Journal of Endocrinology and Metabolism.

Causative anti-diabetic drugs and the underlying clinical factors for hypoglycemia in patients with diabetes.

Hidekatsu Yanai, H. Katsuyama, H. Hamasaki, 2015, World journal of diabetes.

The Treatment for Anti-insulin Antibody-mediated Immunological Insulin Resistance

H. Hamasaki, S. Mishima, H. Yanai, 2011 .

Urate Transporter 1 Can Be a Therapeutic Target Molecule for Chronic Kidney Disease and Diabetic Kidney Disease: A Retrospective Longitudinal Study

H. Katsuyama, H. Yanai, Hiroki Adachi, 2023, Biomedicines.

Chronic Kidney Disease Stage G4 in a Diabetic Patient Improved by Multi-Disciplinary Treatments Based Upon Literature Search for Therapeutic Evidence

H. Yanai, Hiroki Adachi, Naoki Yamaguchi, 2022, Cardiology research.

A Possible Exquisite Crosstalk of Urate Transporter 1 With Other Urate Transporters for Chronic Kidney Disease and Cardiovascular Disease Induced by Dotinurad

H. Katsuyama, H. Yanai, Hiroki Adachi, 2023, Cardiology research.

A significant association between impaired glucose metabolism and polymyalgia rheumatica.

N. Tada, H. Yanai, H. Yoshida, 2010, Journal of atherosclerosis and thrombosis.

The possible contribution of a general glycosphingolipid transporter, GM2 activator protein, to atherosclerosis.

H. Chiba, N. Tada, H. Yanai, 2006, Journal of atherosclerosis and thrombosis.

Relevance of intermediate-density lipoprotein cholesterol to Framingham risk score of coronary heart disease in middle-aged men with increased non-HDL cholesterol.

N. Tada, H. Yanai, H. Yoshida, 2013, International journal of cardiology.

Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virus infection.

H. Yanai, 2014, Hepatobiliary & pancreatic diseases international : HBPD INT.

Oxidized low density lipoprotein elevates platelet serotonin release

N. Tada, H. Yanai, H. Yoshida, 2007, American journal of hematology.

Significance of membrane glycoproteins in platelet interaction with oxidized low-density lipoprotein.

H. Chiba, H. Yanai, K. Matsuno, 1998, Seminars in thrombosis and hemostasis.

Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19

M. Sugiyama, M. Mizokami, T. Kano, 2020, Gene.

Adiposity is the Crucial Enhancer of COVID-19

H. Yanai, 2020, Cardiology research.

Diabetic dyslipidemia: evaluation and mechanism.

H. Yanai, H. Yoshida, Y. Hirowatari, 2019, Global health & medicine.

Significance of Endothelial Dysfunction Amelioration for Sodium–Glucose Cotransporter 2 Inhibitor-Induced Improvements in Heart Failure and Chronic Kidney Disease in Diabetic Patients

H. Katsuyama, T. O’Toole, H. Yanai, 2023, Metabolites.

Hospitalization with hypoglycemia in patients without diabetes mellitus

H. Yasunaga, K. Fushimi, A. Goto, 2017, Medicine.

Effects of Anti-Malarial Drug, Hydroxychloroquine, on Glucose and Lipid Metabolism in Japanese Population

T. Kano, H. Yanai, K. Hiraga, 2019 .

Lipid Abnormalities During Acute Metabolic Complications of Diabetes in Japanese Diabetic Patients

S. Moriyama, H. Yanai, 2019 .

VLDL Is the Leading Actor in Lipid Abnormality in Patients With Diabetes and Obesity

H. Yanai, 2017 .

Understanding of Diabetic Dyslipidemia by Using the Anion-Exchange High Performance Liquid Chromatography Data

N. Tada, H. Yanai, H. Yoshida, 2016, Journal of clinical medicine research.

A Significant Discrepancy Between Endocrinological and Clinical Phenotype and Immunological Phenotype in Autoimmune Polyglandular Syndrome Type 3

H. Hamasaki, S. Moriyama, H. Yanai, 2012 .

Handgrip strength is inversely associated with augmentation index in patients with type 2 diabetes

H. Hamasaki, H. Yanai, 2023, Scientific Reports.

Clinical, radiological, and biochemical characteristics in patients with diseases mimicking polymyalgia rheumatica

N. Tada, H. Yanai, H. Yoshida, 2009, Clinical interventions in aging.

Association of the use of psychotropic drugs with hospitalization, cardiovascular events, and mortality in patients with type 2 diabetes: a propensity score-matched cohort study

H. Hamasaki, H. Yanai, 2023, Frontiers in Clinical Diabetes and Healthcare.

Scintigraphic Findings and Serum Matrix Metalloproteinase 3 and Vascular Endothelial Growth Factor Levels in Patients with PolymyalgiaRheumatica

H. Yanai, H. Yoshida, N. Furutani, 2009 .

Construction of Effective and Safe Glycemic Control in the Elderly by Using Continuous Glucose Monitoring

H. Yanai, Hiroki Adachi, Koki Kakuta, 2017 .

Hospitalization for Hypoglycemia in Japanese Diabetic Patients

H. Yasunaga, K. Fushimi, A. Goto, 2015, Medicine.

Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals

S. Yamashita, T. Okamura, M. Kuzuya, 2020, Journal of atherosclerosis and thrombosis.

Therapeutic Application of Diacylglycerol Oil for Obesity: Serotonin Hypothesis

N. Tada, H. Yanai, H. Yoshida, 2012 .

Plasma B-Type Natriuretic Peptide Levels May Increase Because of Fat Mass Loss by Metformin or Sodium-Glucose Transporter 2 Inhibitors Treatment

H. Hamasaki, H. Yanai, 2016 .

The development of angioedema in a patient with type 2 diabetes due to a novel dipeptidyl peptidase-IV inhibitor, anagliptin.

H. Hamasaki, H. Yanai, 2013, International journal of cardiology.

Bofutsushosan Significantly Ameliorated Betamethasone-Induced Cushing’s Syndrome

H. Yanai, 2018, Journal of clinical medicine research.

Sodium-Glucose Cotransporter 2 Inhibitors: Possible Anti-Atherosclerotic Effects Beyond Glucose Lowering

H. Katsuyama, H. Hamasaki, S. Moriyama, 2015, Journal of clinical medicine research.

Development of diabetes in a familial amyotrophic lateral sclerosis patient carrying the I113T SOD1 mutation. Case Report.

K. Abe, H. Yoshino, H. Hamasaki, 2015, Neuro - endocrinology letters.

Pseudopseudohypoparathyroidism With a Novel Mutation in the GNAS Gene Showing Thin Bones of Extremities and Ossification of Entheses

T. Hasegawa, H. Hamasaki, S. Moriyama, 2013 .

Sodium-Glucose Cotransporter 2 Inhibitors Reduce Prandial Insulin Doses in Type 2 Diabetic Patients Treated With the Intensive Insulin Therapy

H. Yanai, Hiroki Adachi, M. Hakoshima, 2018, Journal of clinical medicine research.

Effects of Low-Intensity Resistance Exercise with Slow Movement and Tonic Force Generation on Short-Term Glycemic Variability in Healthy Subjects: A Randomized Controlled Study

Takuro Shoji, H. Hamasaki, H. Yanai, 2021, Applied Sciences.

A teenager with abdominal pain and soft-tissue emphysema

N. Tada, T. Koyama, H. Yanai, 2006, Canadian Medical Association Journal.

Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB‐4 index in metabolic‐associated fatty liver disease

A. Masamune, H. Katsuyama, Taizo Mori, 2023, Hepatology research : the official journal of the Japan Society of Hepatology.

Adverse drug reaction: a possible case of glimepiride-induced syndrome of inappropriate antidiuretic hormone secretion.

H. Yanai, H. Adachi, 2015, Diabetes & metabolism.

Effects of Diacylglycerol on Glucose, Lipid Metabolism, and Plasma Serotonin Levels in Lean Japanese

N. Tada, H. Yanai, H. Yoshida, 2008, Obesity.

Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments

H. Katsuyama, H. Yanai, M. Hakoshima, 2023, International journal of molecular sciences.

A molecular mechanism for diacylglycerol-mediated promotion of negative caloric balance

N. Tada, H. Yanai, H. Yoshida, 2009, Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy.

Characteristic comparison of triglyceride-rich remnant lipoprotein measurement between a new homogenous assay (RemL-C) and a conventional immunoseparation method (RLP-C)

M. Fernández, N. Tada, J. Volek, 2008, Lipids in Health and Disease.

A Significant Effect of Pemafibrate on Hepatic Steatosis and Fibrosis Indexes in Patients With Hypertriglyceridemia

H. Katsuyama, H. Yanai, M. Hakoshima, 2023, Gastroenterology Research.

Correlations of Body Mass Index, Japan-Defined and IDF-Defined Waist Circumference, Visceral and Subcutaneous Fat Area with Metabolic Parameters in Japanese Patients with Type 2 Diabetes

Hidekatsu Yanai, Yuji Hirowatari, H. Yanai, 2015 .

The Development of Repeated Severe Hypothermia in a House in a Type 2 Diabetic Patient Complicated With Klinefelter’s Syndrome

H. Hamasaki, S. Moriyama, R. Yoshikawa, 2012 .

The Application of Dipeptidyl Peptidase 4 Inhibitor to the Treatment for Hepatitis C Virus Infection

H. Katsuyama, H. Hamasaki, S. Moriyama, 2014 .

Diacylglycerol oil for apolipoprotein C-II deficiency.

N. Tada, H. Yanai, H. Yoshida, 2007, QJM : monthly journal of the Association of Physicians.

Metabolic-Dysfunction-Associated Steatotic Liver Disease—Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments

H. Katsuyama, H. Yanai, M. Hakoshima, 2023, International journal of molecular sciences.

Usefulness of Decreasing Number of Negative T Wave Leads on Electrocardiography for Predicting the Improvement of Pulmonary Hypertension:A Case Report

Yuriko Tanaka, S. Moriyama, Akahito Sako, 2014 .

The association between daily physical activity and plasma B-type natriuretic peptide in patients with glucose intolerance: a cross-sectional study

M. Kakei, H. Hamasaki, H. Yanai, 2015, BMJ Open.

TITLE ( PROVISIONAL ) The association between daily physical activity and plasma B-type natriuretic peptide in patients with glucose intolerance : a cross-sectional study AUTHORS

O. Ezaki, M. Kakei, H. Hamasaki, 2014 .

Not visceral fat area but the ratio of visceral to subcutaneous fat area is significantly correlated with the marker for atherosclerosis in obese subjects.

H. Katsuyama, H. Yanai, Akiko Kawaguchi, 2015, International journal of cardiology.

Measurement of cholesterol levels of lipoprotein subclasses in human serum using anion-exchange high-performance liquid chromatography with a linear concentration gradient of sodium perchlorate

H. Yanai, Riku Ito, Y. Hirowatari, 2023, Annals of clinical biochemistry.

The underlying mechanisms for development of hypertension in the metabolic syndrome

N. Tada, H. Yanai, H. Yoshida, 2008, Nutrition Journal.

Correlations of Arterial Stiffness and Augmentation Index With Metabolic Risk Factors in Patients With Type 2 Diabetes

H. Yanai, 2016, Journal of clinical hypertension.

Association of Serum Uric Acid Concentration With Metabolic Risk Factors in Patients With Type 2 Diabetes

H. Yanai, Y. Hirowatari, 2015, Journal of clinical hypertension.

Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications

H. Katsuyama, H. Yanai, M. Hakoshima, 2023, Biology.

Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia.

N. Tada, H. Yanai, H. Yoshida, 2010, Atherosclerosis.

A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease

H. Katsuyama, H. Yanai, M. Hakoshima, 2024, Cells.

The validity of the non-exercise activity thermogenesis questionnaire evaluated by objectively measured daily physical activity by the triaxial accelerometer

O. Ezaki, M. Kakei, H. Hamasaki, 2014, BMC Sports Science, Medicine and Rehabilitation.